Efficacy and safety of the first domestic pegilated interferon alpha-2b «Pegaltevir» at chronic hepatitis C: pilot data of phase III clinical study

Efficacy and safety of the first domestic pegilated interferon alpha-2b «Pegaltevir» at chronic hepatitis C: pilot data of phase III clinical study

Aim of investigation. Comparative assessment of efficacy and safety of Pegaltevir and PegIntron in within pattern of combined antiviral therapy in previously untreated patients with chronic hepatitis C.Material and methods. Overall 140 patients with chronic hepatitis C, who received no antiviral the...

Full description

Saved in:
Bibliographic Details
Main Authors: V. T. Ivashkin, Ye. N. Bessonova, P. O. Bogomolov, N. I. Geyvandova, K. V. Zhdanov, M. V. Mayevskaya, V. G. Morozov, V. D. Pasechnikov, I. Yu. Khomenko, A. V. Yagoda
Format: Article
Language:Russian
Published: Gastro LLC 2014-07-01
Series:Российский журнал гастроэнтерологии, гепатологии, колопроктологии
Subjects:
chronic hepatitis c
treatment
peginterferon alpha-2b
pegaltevir
Online Access:https://www.gastro-j.ru/jour/article/view/1090
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.gastro-j.ru/jour/article/view/1090

Similar Items